Rezum FIM Optimization Study

Clinical trial NCT02940392 · COMPLETED

Trial details

NCT number: NCT02940392
Sponsor: Boston Scientific Corporation
Status: COMPLETED
Phase: Not Applicable
Study type: INTERVENTIONAL

Benign Prostatic Hyperplasia Adenoma, Prostatic Prostatic Adenoma Prostatic Hyperplasia, Benign Prostatic Hypertrophy Prostatic Hypertrophy, Benign Rezum

Start date: 2012-03-19
Primary completion: 2017-05-19
Enrollment: 15

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.